Free Trial

Kellanova (NYSE:K) Shares Bought Rep. Robert Bresnahan, Jr.

Kellanova logo with Consumer Discretionary background

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently bought shares of Kellanova NYSE: K. In a filing disclosed on May 08th, the Representative disclosed that they had bought between $1,001 and $15,000 in Kellanova stock on April 8th. The trade occurred in the Representative's "JP MORGAN BROKERAGE ACCOUNT" account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/17/2025.
  • Sold $1,001 - $15,000 in shares of Meta Platforms NASDAQ: META on 4/16/2025.
  • Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/11/2025.
  • Sold $1,001 - $15,000 in shares of Western Digital NASDAQ: WDC on 4/10/2025.
  • Sold $1,001 - $15,000 in shares of DexCom NASDAQ: DXCM on 4/8/2025.
  • Sold $1,001 - $15,000 in shares of Invesco NYSE: IVZ on 4/8/2025.
  • Sold $1,001 - $15,000 in shares of Generac NYSE: GNRC on 4/8/2025.
  • Sold $15,001 - $50,000 in shares of Occidental Petroleum NYSE: OXY on 4/8/2025.
  • Sold $15,001 - $50,000 in shares of Pfizer NYSE: PFE on 4/8/2025.
  • Sold $1,001 - $15,000 in shares of QUALCOMM NASDAQ: QCOM on 4/8/2025.

Kellanova Trading Down 0.0 %

Shares of K stock opened at $82.50 on Friday. The firm's 50-day simple moving average is $82.39 and its 200-day simple moving average is $81.70. The company has a debt-to-equity ratio of 1.29, a current ratio of 0.81 and a quick ratio of 0.56. Kellanova has a 1-year low of $55.96 and a 1-year high of $83.22. The firm has a market cap of $28.48 billion, a P/E ratio of 21.32, a PEG ratio of 4.21 and a beta of 0.30.

Kellanova (NYSE:K - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.90 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.11). Kellanova had a net margin of 10.53% and a return on equity of 37.25%. The firm had revenue of $3.08 billion during the quarter, compared to analyst estimates of $3.16 billion. During the same period in the prior year, the firm earned $1.01 earnings per share. The business's revenue for the quarter was down 3.7% on a year-over-year basis. As a group, equities analysts forecast that Kellanova will post 3.93 EPS for the current year.

Kellanova Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Monday, June 2nd will be paid a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a yield of 2.76%. Kellanova's payout ratio is 57.58%.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in K. Grove Bank & Trust bought a new stake in Kellanova in the first quarter worth about $25,000. Stonebridge Financial Group LLC purchased a new position in shares of Kellanova during the fourth quarter valued at $27,000. MorganRosel Wealth Management LLC purchased a new position in Kellanova during the 1st quarter valued at about $27,000. BankPlus Trust Department acquired a new position in Kellanova in the 4th quarter valued at approximately $28,000. Finally, Rialto Wealth Management LLC purchased a new stake in shares of Kellanova during the fourth quarter worth $32,000. Institutional investors and hedge funds own 83.87% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on K shares. Royal Bank of Canada lowered shares of Kellanova from a "moderate buy" rating to a "hold" rating in a report on Friday, March 14th. StockNews.com lowered shares of Kellanova from a "buy" rating to a "hold" rating in a research note on Friday, May 2nd. Thirteen analysts have rated the stock with a hold rating and one has assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $79.41.

Get Our Latest Stock Analysis on K

Insider Activity

In other news, major shareholder Kellogg W. K. Foundation Trust sold 114,583 shares of the firm's stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $82.25, for a total value of $9,424,451.75. Following the sale, the insider now directly owns 48,076,612 shares of the company's stock, valued at approximately $3,954,301,337. This trade represents a 0.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders sold a total of 1,374,996 shares of company stock worth $113,261,858 in the last three months. 1.80% of the stock is owned by insiders.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania's 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania's 8th Congressional District. He declared candidacy for the 2026 election. Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

Kellanova Company Profile

(Get Free Report)

Kellanova, together with its subsidiaries, manufactures and markets snacks and convenience foods in North America, Europe, Latin America, the Asia Pacific, the Middle East, Australia, and Africa. Its principal products include crackers, crisps, savory snacks, toaster pastries, cereal bars, granola bars and bites, ready-to-eat cereals, frozen waffles, veggie foods, and noodles.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kellanova Right Now?

Before you consider Kellanova, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kellanova wasn't on the list.

While Kellanova currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
3 Sectors With Massive Momentum You Can’t Afford to Miss
Palantir’s Big Moves: Profit-Taking, Price Targets & AI Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines